Nuvectis Pharma, Inc. Common Stock (NVCT) is a publicly traded Healthcare sector company. As of October 9, 2026, NVCT trades at $20.51 with a market cap of $662.35M and a P/E ratio of -15.24. NVCT moved +0.00% today. Year to date, NVCT is +136.54%; over the trailing twelve months it is +223.11%. Its 52-week range spans $5.55 to $29.28. Analyst consensus is strong buy with an average price target of $34.00. Rallies surfaces NVCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks NVCT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $20.51 |
| Market Cap | $662.35M |
| P/E Ratio | -15.24 |
| EPS | $-1.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.28 |
| 52-Week Low | $5.55 |
| Volume | 4.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.44M |
| Gross Margin | 0.00% |
5 analysts cover NVCT: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.00.